Seeing Machines Limited (LON:SEE) has secured a new programme design win for its Driver Monitoring System technology with a US-based original equipment manufacturer.
Arc Minerals Ltd. (LON:ARCM) has raised £2.2mln through a placing of 73.6mln units at 3p each, with each unit consisting of one share and one warrant. The money raised will be used to fund the continuing exploration and development work on the Zamsort copper project in Zambia and for general working capital purposes.
Strategic Minerals PLC (LON:SML) (USOTC: SMCDY) announced that its managing director, John Peters and chairman, Alan Broome gave exercised 17,500,000 existing vested options. Accordingly, the group added, Peters has subscribed for 16,000,000 new ordinary shares taking his holding in the company to 50,500,000 ordinary shares of 3.6% of its total issued share capital. The group said Broome has subscribed for 1,500,000 new ordinary shares, increasing his holding to 6,147,319 ordinary shares, or 0.44% of the total issued share capital.
FairFX Group Plc (LON:FFX) has been given access to settlement accounts at the Bank of England following an extensive audit, in a move it said represented “a significant endorsement” of its services.
Belluscura, one of Tekcapital PLC’s (LON:TEK) portfolio companies, has filed for another patent for its X-PLOR portable oxygen concentrator ahead of its planned commercial launch later this year. Tekcapital said Belluscura, in which it holds a 29% stake, has filed a broad patent application covering oxygen enrichment inventions relating to a portable artificial lung and wound care devices.
Diversified Gas & Oil PLC (LON:DGOC) has struck a deal with the Kentucky authorities over its field retirement obligations for the next five years. It relates to the assets acquired by DGOC in its 2018 transaction with Core Appalachia Holding Co LLC.
Touchstone Exploration Inc (LON:TXP) has raised £3.8mln through a share placing to fund a new exploration well in Trinidad. The capital injection will support the proposed drilling of an exploration well in the Corosan west region of its Ortoire exploration property. It is planned that drilling will kick off in the second quarter.
Arix Bioscience PLC (LON:ARIX) said chief investment officer Joe Anderson has been re-appointed chief executive. Executive chairman Jonathan Peacock will stay in role, but in a non-executive capacity at the life sciences investment company, while biotechnology entrepreneur Sir Christopher Evans is retiring as a director after a three-year term. Evans will continue as a consultant.
In a later statement, Arix Bioscience also noted that its portfolio company, Autolus Therapeutics PLC (NASDAQ:AUTL) has presented updated data from the ongoing Phase 1 CARPALL trial of AUTO1 in a poster presentation at the European Hematology Association 1st European CAR T Cell Meeting held in Paris, France, February 14-16, 2019.
Primary Health Properties PLC (LON:PHP) has contracted to fund and acquire a purpose built primary care centre in County Kildare.
Red Rock Resources PLC (LON:RRR) noted that Jupiter Mines Limited (ASX:JMS), an Australian company in which the UK firm owns a 0.95% holding, has announced a final unfranked dividend of 0.025 per share. Red Rock Chairman Andrew Bell said: "Based on Red Rock's shareholding in Jupiter, we will receive A$463,122.85, or approximately US$329,140 at today's exchange rate, as a Final Dividend in May 2019. This follows a US$658,545.69 interim payment in October 2018.”
Asiamet Resources LTD (LON:ARS) is continuing to intersect broad intervals of copper mineralisation with high grade intervals in ongoing drilling at its Beruang Kanan Main project (BKM) in Indonesia. The drilling comprises part of the ongoing bankable feasibility study on the project.
Block Energy Plc (LON:BLOE), the exploration and production company focused on the Republic of Georgia, announced that its CEO, Paul Haywood, will be hosting an investor presentation lunch on Thursday 21 February at 12pm to provide a presentation on the Company's strategy and answer investors' questions at Bangers, 2 Wilson Street, Moorgate, London, EC2M 2TE.
Motif Bio Plc (LON:NASDAQ) (LON:MTFB), the clinical-stage biopharmaceutical company specialising in developing novel antibiotics, said it will hold a conference call on Tuesday, February 19, 2019 - at 8:30 AM ET/1:30 PM GMT/2:30 PM CET - to discuss recent events and the company's plans.